Garrison Point Advisors LLC Has $466,000 Holdings in Agilent Technologies, Inc. (NYSE:A)

Garrison Point Advisors LLC trimmed its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 6.0% during the third quarter, HoldingsChannel reports. The fund owned 3,140 shares of the medical research company’s stock after selling 200 shares during the period. Garrison Point Advisors LLC’s holdings in Agilent Technologies were worth $466,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC lifted its stake in Agilent Technologies by 2.8% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 25,107 shares of the medical research company’s stock valued at $3,653,000 after acquiring an additional 695 shares in the last quarter. Kathmere Capital Management LLC bought a new stake in shares of Agilent Technologies in the first quarter worth $243,000. S.E.E.D. Planning Group LLC lifted its position in shares of Agilent Technologies by 2.4% in the first quarter. S.E.E.D. Planning Group LLC now owns 33,762 shares of the medical research company’s stock worth $4,913,000 after purchasing an additional 795 shares in the last quarter. Occidental Asset Management LLC grew its position in Agilent Technologies by 0.9% in the first quarter. Occidental Asset Management LLC now owns 19,740 shares of the medical research company’s stock valued at $2,872,000 after purchasing an additional 171 shares in the last quarter. Finally, Grimes & Company Inc. increased its stake in Agilent Technologies by 3.1% in the 1st quarter. Grimes & Company Inc. now owns 112,465 shares of the medical research company’s stock valued at $16,365,000 after buying an additional 3,392 shares during the last quarter. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Wells Fargo & Company began coverage on Agilent Technologies in a report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective for the company. Bank of America upped their price objective on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Citigroup increased their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI boosted their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $144.36.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,995 shares of company stock worth $1,739,510. Company insiders own 0.33% of the company’s stock.

Agilent Technologies Trading Down 1.7 %

Shares of Agilent Technologies stock opened at $130.72 on Friday. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.35. The stock has a market cap of $38.14 billion, a PE ratio of 30.90, a PEG ratio of 6.96 and a beta of 1.05. The firm has a 50-day moving average of $140.91 and a 200-day moving average of $138.59. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the business posted $1.43 EPS. The business’s revenue was down 5.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a dividend of $0.236 per share. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.72%. Agilent Technologies’s payout ratio is 22.22%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.